We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byJustin Daniels
Modified over 3 years ago
Solange Arazi Caillaud. MD Emiliano Bissio. MD María Ester Lázaro. MD
99% of men love Football 99% of what she says about us, is unfortunatly true Less than 30% of argentines dance tango 80% of argentines drink mate
Total Population 40 Millions HIV infected 120 000 People who know their HIV status 60 000 (50%) People on follow up 56 000 69% public health 31% security system
DISTRIBUTION OF HIV INFECTED PATIENTS ARGENTINA- 2008 Buenos Aires city and suburbs: 44% Central Area: 27%
Routes of transmission Argentina (2005-2008) MenWomen 48% 34% 87%
CD4 Viral load Resistance test PCR-HIV(MTCT) ARV Drugs for treatment and prophylaxis of opportunistic infections NRTI Zidovudine Lamivudine Stavudine Didanosine Tenofovir Abacavir Emtricitabine+ tenofovir NNRTI Nevirapine Efavirenz Etravirine PI Nelfinavir Indinavir Ritonavir Saquinavir Amprenavir Lopinavir+ritonavir Fosamprenavir Tipranavir Atazanavir Darunavir Integrase Inhibitor Raltegravir Co-Receptor antagonist Maraviroc Fusion Inhibitor Enfuvirtide ( T20)
Rate of MTCT per 10000 newborn Age at diagnosis of the children perinatally infected. N= 3898 67% 2 years old Number of children Age (years)
Thanks EACS for this great oportunity!
© IAS–USA Johnson VA et al. Top Antivir Med. 2011;19(4): Updates, user notes, and references available at Mutations in the.
© IAS–USA Johnson VA et al. Top Antivir Med. 2013;21(1):4-12. Updates, user notes, and references available at Mutations in the Reverse.
Antiretroviral targets in the viral life cycle Viral Replication and Drug targets.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Dr Emmanuel Nsutebu Consultant Infectious Diseases Physician Tropical and Infectious Diseases Unit Royal Liverpool Hospital HIV “Myths, controversies and.
ANTIRETROVIRAL RESISTANCE Jennifer Fulcher, MD, PhD.
Medicines Patent Pool and Seychelles A primer For more information visit:
HIV Situation in India Dr Sunil Gaikwad. HIV/AIDS In India Approximate population of India: 1.21 billion (Census 2011 ) 1986: First case of HIV detected.
HIV: WHAT IS NEW? DR NYA EBAMA, M.D. LOWCOUNTRY INFECTIOUS DISEASES, PA CARETEAM PLUS, INC SEPTEMBER 18, 2015.
ARV failure and resistance for the paediatrician Douglas Watson, M.D. University of Maryland 11 December 2013.
ANTIRETROVIRAL THERAPY Dr. Samuel Mwaniki (BPharm., MSc TID, UoN) University of Nairobi ISO 9001: Certified
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 94 Antiviral Agents II: Drugs for HIV Infection and.
The Medicines Patent Pool advancing innovation, expanding access, promoting public health Charles Clift Chair, Medicines Patent Pool
After completing this session the participant should be able to: Discuss the goals of HIV treatment. Understand when resistance testing should be.
HIV Care 2010: The 3 rd Revolution in HIV treatment Chris Farnitano, MD Noon Conference February 11, 2010.
Ministry of Health Health Surveillance Secretariat NATIONAL STD/AIDS PROGRAMME.
HIV/AIDS in Argentina Vanesa Fridman, MD Infectious Disease Hospital de Clinicas Universidad de Buenos Aires, Argentina.
ANTIVIRAL THERAPY DR FATAI OLUYADI USMLEINCLINED.COM 1.
Presented by: Siti Rohaizah bt Othman. Arv DRUGS AVAILABLE IN UMMC Combivir (Lamivudine + Zidovudine) Stocrin (Efavirenz 600mg) Kaletra (Lopinavir 200mg.
Rodrigo Zilli Haanwinckel Ministry of Health of Brazil Health Surveillance Secretariat Department of STD, AIDS and Hepatitis Prevention of vertical transmission.
MANAGEMENT OF HIV Involves both treatment of the virus and prevention of opportunistic infections. The aims of HIV treatment are : 1. Reduce the viral.
Why African Americans Must Understand and Participate in Clinical Trials and Vaccines Virginia A. Caine, M.D. Associate Professor of Medicine Division.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 93 Antiviral Agents II: Drugs for HIV Infection and Related.
MONITORING SYSTEM FOR THE ANTIRETROVIRAL THERAPY IN BRAZIL: LESSONS LEARNED AND FUTURE DIRECTIONS Marco Vitória, MD Brazilian STD/AIDS Programme - MOH.
Insight into Hungarian HIV situation 9th Advanced HIV Course, EACS , Aix en Provence Botond Lakatos, HU.
The UNAIDS Investment Framework: Setting priorities for HIV prevention in today’s global economic climate Resource allocation decisions for HIV prevention.
Human Immunodeficiency Virus and Antiretroviral Therapy Lucille Sanzero Eller, PhD, RN Associate Professor Rutgers, The State University of New Jersey.
Measuring Adherence to Chronic Disease Treatment Using Dispensing Data: An Example from Thailand Sauwakon Ratanawijitrasin, PhD Sanita Hirunrassamee, PhD.
AIDS ΘΕΡΑΠΕΙΑ Κατευθυντήριες Οδηγίες ΓΕΩΡΓΙΟΣ ΠΑΝΟΣ BSc(Biomed.Eng.), CEng, MIET, MD, PhD, DTM&H(Lon), FRCP Αν. Καθηγητής Παθολογίας & Λοιμωδών Νοσημάτων.
Understanding mucosal immunity and HIV transmission: the way to new prevention technologies Robin Shattock Centre for Infection, Division of Cellular &
Antiretroviral drugs in UMMC Presenter: TE CHIN YEW Preceptor: KHOO SU LIN.
Welcome to UW I-TECH HIV/AIDS Clinical Seminar Series July 24th, 2008 HIV Lifecycle and Mechanisms of Antiretroviral Therapy David Spach, MD.
+ Antiretroviral Agents: HIV & AIDS Shaw Vonder Hoya.
ANTIRETROVIRAL DRUGS IN THE PERINATAL PERIOD. Use of ARV Drugs by HIV-Infected Pregnant Women and Their Infants Considerations for choice of ARV drugs.
Current Concepts in HIV/AIDS A Pharmacy Perspective Carol Schneiderman, Pharm D Clinical Pharmacist, University of Arizona.
Indications for Initiation of ARV Therapy in Children Age >1 Year Clinical Category CD4 + Cell Percentage Plasma HIV RNA Copy Number Recommendation AIDS.
Slide #1 HIV Entry Inhibitors Trip Gulick, MD, MPH Director, Cornell HIV Clinical Trials Unit Associate Professor of Medicine Weill Medical College of.
HIV Therapy Experience is the Best Teacher David K. Stein, M.D. Director, Adult HIV Research Activities Jacobi Medical Center Associate Professor of Clinical.
Ministry of Health National STD/AIDS Programme Universal Access to Antiretroviral Therapy: The Brazilian Experience.
Slide #1 Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society USA Panel Melanie A. Thompson, MD;
Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department July 20th, 2014 Evidence.
Introduction to new drugs: I-Base training London - May 2007 Introduction to new drugs African Treatment Advocacy Training 31 May 2007 Simon Collins
Track B Workshop Controversies in the Management of HIV-positive Adults: A Case-Based Approach Sasisopin Kiertiburanakul, MD, MHS Associate Professor Department.
Innovative Strategies for the Management of HIV Infection Dual therapies without NRTIs Jean-Guy Baril, MD Clinique médicale du Quartier Latin CHUM This.
Pre Test !!!!!!. How many classes of HIV meds are currently available?
HIV Update Dr Hugh Mc Gann Consultant in Infectious Diseases Leeds Teaching Hospitals.
AN OVERVIEW OF PHARMACOVIGILANCE OF HIV/AIDS IN NIGERIA AN OVERVIEW OF PHARMACOVIGILANCE OF HIV/AIDS IN NIGERIA Pharm.. H. A. ABOJE (NPC), NAFDAC, Nigeria.
Trends in HIV prevalence and HIV incidence in South Africa Thomas M. Rehle, MD, PhD Human Sciences Research Council (HSRC) Cape Town, South Africa AIDS.
© 2017 SlidePlayer.com Inc. All rights reserved.